Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Cream

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    1,074 result(s) found for: Cream. Displaying page 4 of 54.
    « Previous 1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2019-002643-23 Sponsor Protocol Number: STH19966 Start Date*: 2020-03-23
    Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust
    Full Title: Validation of a novel composite of skin biomarkers as a primary outcome measure for evaluating the safety of treatments for atopic dermatitis: a randomized controlled trial (phase 2) comparing the ...
    Medical condition: atopic eczema (synonym atopic dermatitis) and the adverse treatment side effect epidermal atrophy
    Disease: Version SOC Term Classification Code Term Level
    21.1 10040785 - Skin and subcutaneous tissue disorders 10003641 Atopic eczema LLT
    21.0 10040785 - Skin and subcutaneous tissue disorders 10040799 Skin atrophy PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2009-017647-34 Sponsor Protocol Number: ANTIRESDEV Start Date*: 2010-03-29
    Sponsor Name:Helperby Therapeutics
    Full Title: Effect of minocycline and amoxicillin administration on the prevalence of antibiotic resistant bacteria and on the indigenous oral, faecal, cutaneous and nasal microbiotas.
    Medical condition: Amoxicillin and Minocycline are marketed antibiotic to fight bacterial infections.
    Disease: Version SOC Term Classification Code Term Level
    12 10002737 Antibiotic Resistant Strain SOC
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-017398-39 Sponsor Protocol Number: HT-04 Start Date*: 2010-02-02
    Sponsor Name:Helperby Thearapeutics Ltd
    Full Title: Randomised double-blind, vehicle controlled dosing frequency study of HT61 1% gel applied to the anterior nares plus chlorhexidine body and hair washes in subjects with nasal carriage of Staphyloco...
    Medical condition: Nasal carriage of Staphylococcus aures (including MRSA)
    Disease: Version SOC Term Classification Code Term Level
    12 10067910 Staphylococcal colonisation LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2008-007067-16 Sponsor Protocol Number: TERJ001 Start Date*: 2009-02-11
    Sponsor Name:JELFA SA
    Full Title: Randomised, double-blind, parallel-group, comparative study of two terbinafine products
    Medical condition: tinea pedis (interdigital, Athlet´s foot)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-003537-41 Sponsor Protocol Number: VAN001/2005 Start Date*: 2005-10-27
    Sponsor Name:TRICHOLOG GmbH
    Full Title: Efficacy of the treatment with VANIQA 11,5% creme in patients suffering from hirsutism of the upper lip
    Medical condition: Hirsutism of the upper lip in female patients suffering from increased hair growth in the face
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-002540-13 Sponsor Protocol Number: RD.06.SPR.18252 Start Date*: 2016-01-13
    Sponsor Name:Galderma R&D SNC
    Full Title: A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 50μg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris
    Medical condition: Acne Vulgaris
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004858 10000519 Acne vulgaris LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) ES (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2020-002219-24 Sponsor Protocol Number: IMPET-001 Start Date*: 2020-08-17
    Sponsor Name:Basic Pharma Technologies
    Full Title: A Randomized, Double-Blind, Parallel Group, Equivalence, Multicenter Phase III Trial to Compare the Efficacy and Safety of Fusidic Acid Hydrophilic Cream 20 mg/g and Fucidin® Cream in the Treatment...
    Medical condition: Impetigo contagiosa
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10021531 Impetigo PT
    20.0 10021881 - Infections and infestations 10041923 Staphylococcal impetigo PT
    20.0 10021881 - Infections and infestations 10042178 Streptococcal impetigo PT
    20.0 10021881 - Infections and infestations 10021535 Impetigo NOS LLT
    20.1 10021881 - Infections and infestations 10041939 Staphylococcus aureus impetigo LLT
    20.0 10021881 - Infections and infestations 10042200 Streptococcus pyogenes impetigo LLT
    20.1 10021881 - Infections and infestations 10021533 Impetigo contagious LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed) CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-001062-17 Sponsor Protocol Number: ASF-1096-201/250912BS Start Date*: 2006-11-30
    Sponsor Name:Astion Danmark A/S
    Full Title: Efficacy and safety of ASF-1096 cream 0.5% in the treatment of patients with newly developed discoid lupus erythymatosus (DLE) lesions. A multi centre clinical phase 2, placebo controlled and doubl...
    Medical condition: Male or female patients with a clinical diagnosis of either Discoid Lupus Erythmatosus or Systemic Lupus Erythmatosus and at least one newly developed, sharply demarcated DLE lesion.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10025138 Lupus erythematosus discoides LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) SE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2015-004899-30 Sponsor Protocol Number: 111187 Start Date*: 2016-12-21
    Sponsor Name:GlaxoSmithKline Research & Development Ltd.
    Full Title: Multi-center, Randomised, Double-blind, Parallel, Placebo Controlled Study Of 0.05% Clobetasone Butyrate Cream in Subjects with Eczema to evaluate the Efficacy and Safety.
    Medical condition: Eczema
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2019-004119-30 Sponsor Protocol Number: IP-AVV2019 Start Date*: 2020-01-08
    Sponsor Name:Instituto Palacios
    Full Title: EVALUATION OF THE ACCEPTABILITY AND EFFICACY OF 10 MICROGRAMS OF ESTRADIOL VAGINAL TABLETS VS PROMESTRIENE VAGINAL CREAM
    Medical condition: VULVOVAGINAL ATROPHY
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2014-003610-86 Sponsor Protocol Number: EMCD1403 Start Date*: 2014-11-14
    Sponsor Name:
    Full Title: A double blind randomized controlled trial comparing the efficacy of 7% lidocaine / 7% tetracaine cream versus 2,5% lidocaine / 2,5% prilocaine cream for local anaesthesia during laser treatment of...
    Medical condition: Pain during laser treatment of: 1. Tattoo 2. Acne keloidalis nuchae
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-002738-39 Sponsor Protocol Number: 04-7-011 Start Date*: 2006-09-22
    Sponsor Name:Astelleas Pharma US, Inc.
    Full Title: A Phase 1 Open-Label Study of the Pharmacokinetics of Tacrolimus Cream B 0.1% after Twice Daily Topical Administration in Adolescents (≥ 12 to ≤ 17 Years of Age ) with Psoriasis
    Medical condition: Determination of pharmacokinetics and safety of tacrolimus in adolescents with plaque psoriasis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10037153 Psoriasis LLT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: LV (Completed)
    Trial results: View results
    EudraCT Number: 2009-016627-56 Sponsor Protocol Number: H552000-0920 Start Date*: 2009-12-23
    Sponsor Name:Almirall Hermal GmbH
    Full Title: A phase IIa, multi-center, randomized, double-blind study to evaluate the anti-mycotic and anti-inflammatory efficacy of topical combinational product LAS 41003 versus corresponding mono-substances...
    Medical condition: 96 male or female patients with candida infections in intertriginous areas at the trunk will be randomized
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2018-001705-91 Sponsor Protocol Number: HEHDZ02 Start Date*: 2018-09-26
    Sponsor Name:Center for Perioperative Optimization, Department of Surgery, Herlev Hospital
    Full Title: MELADERM-trial: Melatonin cream against acute radiation dermatitis in patients with early breast cancer: a pivotal phase 2, double-blind, randomized, placebo-controlled trial
    Medical condition: Radiation dermatitis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10022117 - Injury, poisoning and procedural complications 10061103 Dermatitis radiation LLT
    20.1 10022117 - Injury, poisoning and procedural complications 10063562 Radiation skin injury PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2008-006148-20 Sponsor Protocol Number: 071-005 Start Date*: 2009-01-07
    Sponsor Name:GALENpharma GmbH
    Full Title: A vehicle-controlled, investigator-blinded intraindividual comparison to evaluate the safety, tolerability and efficacy of Momegalen rich cream and ointment in patients with hand and foot eczema an...
    Medical condition: hand and foot eczema, mild to moderate psoriasis vulgaris
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-002367-24 Sponsor Protocol Number: PC TA001/04 Start Date*: 2004-10-20
    Sponsor Name:PhotoCure ASA
    Full Title: A blinded, prospective, randomised, placebo-controlled, multi-centre, split-face study of photodynamic therapy with Metvix 160 mg/g cream in subjects with acne vulgaris.
    Medical condition: Moderate inflammatory acne vulgaris.
    Disease:
    Population Age: Adolescents, Under 18, Adults Gender: Male
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2019-000847-28 Sponsor Protocol Number: INCB18424-307 Start Date*: 2020-05-05
    Sponsor Name:Incyte Corporation
    Full Title: A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Extension Period in Participants With Vitiligo
    Medical condition: Vitiligo
    Disease: Version SOC Term Classification Code Term Level
    21.1 10040785 - Skin and subcutaneous tissue disorders 10047642 Vitiligo PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) FR (Completed) PL (Completed) BG (Completed) ES (Completed) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2010-019422-13 Sponsor Protocol Number: 2010-1 Start Date*: 2010-08-03
    Sponsor Name:Medical University of Graz
    Full Title: An open monocentric pilot study to investigate the potential of imiquimod 5% cream to detect residual and to prevent recurrence of lentigo maligna after surgical excision
    Medical condition: An open monocentric pilot study to investigate the potential of imiquimod 5% cream to detect residual and to prevent recurrence of lentigo maligna after surgical excision
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2013-005062-19 Sponsor Protocol Number: FDA-BE1 Start Date*: 2015-01-07
    Sponsor Name:Medical University of Graz - Division of Endocrinology and Metabolism
    Full Title: An exploratory study to evaluate dermal open flow microperfusion’s (dOFM) ability to assess bioequivalence and non-bioequivalence of topical acyclovir formulations in healthy volunteers
    Medical condition: healthy volunteers (the medication that is used is authorized)
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2004-001273-26 Sponsor Protocol Number: CASM981CES02 Start Date*: 2004-08-02
    Sponsor Name:NOVARTIS FARMACEUTICA, S.A
    Full Title: A 3 weeks study randomized, multicenter, double blind, vehicle controlled , parallel-group to evaluate the efficacy and safety of Pimecrolimus cream 1% in children between 2 – 11 years with mild to...
    Medical condition: Mild to moderate Atopic Dermatitis
    Disease: Version SOC Term Classification Code Term Level
    7.0 10003641 LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    « Previous 1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 29 20:17:50 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA